TLPHTalphera, Inc.

$18M

FY 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$2M+6.4% YoY

Gross Profit

-$5M-197.3% margin

Operating Income

-$54M-2368.1% margin

Net Income

-$53M-2325.9% margin

EPS (Diluted)

$-13.45

Cash Flow

Operating Cash Flow

-$51M

Free Cash Flow

-$55M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$91M

Total Liabilities

$133M

Stockholders' Equity

-$41M

Cash & Equivalents

$15M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$2M	+6.4%
Gross Profit	-$5M	-$2M	-147.5%
Operating Income	-$54M	-$36M	-51.7%
Net Income	-$53M	-$47M	-12.9%

TLPH FY 2019 Earnings — Talphera, Inc. Revenue & Financial Results | Market Cap Arena